Cargando…
Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma
INTRODUCTION: Histiocytic Sarcoma (HS) is a rare and aggressive malignancy, and patients can present with rapid tumor growth and invasion. The optimal diagnostic and therapeutic management is unknown since only a few cases have been published. Here we report a patient with histiocytic sarcoma of the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215356/ https://www.ncbi.nlm.nih.gov/pubmed/34164336 http://dx.doi.org/10.3389/fonc.2021.633215 |
_version_ | 1783710235107524608 |
---|---|
author | Wehrmann, Stefan Rudolph, Hagen Ernst, Dominikus Siepmann, Timo Kaltofen, Dorothea Hänel, Mathias Mirow, Lutz |
author_facet | Wehrmann, Stefan Rudolph, Hagen Ernst, Dominikus Siepmann, Timo Kaltofen, Dorothea Hänel, Mathias Mirow, Lutz |
author_sort | Wehrmann, Stefan |
collection | PubMed |
description | INTRODUCTION: Histiocytic Sarcoma (HS) is a rare and aggressive malignancy, and patients can present with rapid tumor growth and invasion. The optimal diagnostic and therapeutic management is unknown since only a few cases have been published. Here we report a patient with histiocytic sarcoma of the right groin. CASE: A 68 year-old male patient presented to our hospital with suspicion of a superinfected atheroma of the right groin. Computed tomography showed an abdominal tumor of unknown entity. Detailed assessment including immunohistochemically evaluation of biopsy material confirmed HS. The patient underwent radical tumor resection including compartment-resection of the right thigh. During five additional cycles of chemotherapy over a period of 1.5 years he remained relapse-free. SUMMARY: Diagnostic work up and treatment of HS is challenging, as there is a paucity of clinical reports and lack of standard guidelines for care. In the present case report, aggressive multidisciplinary treatment resulted in good clinical outcome, however, further studies evaluating this approach in similar patients are needed. |
format | Online Article Text |
id | pubmed-8215356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82153562021-06-22 Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma Wehrmann, Stefan Rudolph, Hagen Ernst, Dominikus Siepmann, Timo Kaltofen, Dorothea Hänel, Mathias Mirow, Lutz Front Oncol Oncology INTRODUCTION: Histiocytic Sarcoma (HS) is a rare and aggressive malignancy, and patients can present with rapid tumor growth and invasion. The optimal diagnostic and therapeutic management is unknown since only a few cases have been published. Here we report a patient with histiocytic sarcoma of the right groin. CASE: A 68 year-old male patient presented to our hospital with suspicion of a superinfected atheroma of the right groin. Computed tomography showed an abdominal tumor of unknown entity. Detailed assessment including immunohistochemically evaluation of biopsy material confirmed HS. The patient underwent radical tumor resection including compartment-resection of the right thigh. During five additional cycles of chemotherapy over a period of 1.5 years he remained relapse-free. SUMMARY: Diagnostic work up and treatment of HS is challenging, as there is a paucity of clinical reports and lack of standard guidelines for care. In the present case report, aggressive multidisciplinary treatment resulted in good clinical outcome, however, further studies evaluating this approach in similar patients are needed. Frontiers Media S.A. 2021-06-07 /pmc/articles/PMC8215356/ /pubmed/34164336 http://dx.doi.org/10.3389/fonc.2021.633215 Text en Copyright © 2021 Wehrmann, Rudolph, Ernst, Siepmann, Kaltofen, Hänel and Mirow https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wehrmann, Stefan Rudolph, Hagen Ernst, Dominikus Siepmann, Timo Kaltofen, Dorothea Hänel, Mathias Mirow, Lutz Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma |
title | Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma |
title_full | Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma |
title_fullStr | Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma |
title_full_unstemmed | Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma |
title_short | Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma |
title_sort | case report: eighteen month relapse- free survival following radical multidisciplinary oncological treatment in a 68-year-old male patient with histiocytic sarcoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215356/ https://www.ncbi.nlm.nih.gov/pubmed/34164336 http://dx.doi.org/10.3389/fonc.2021.633215 |
work_keys_str_mv | AT wehrmannstefan casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma AT rudolphhagen casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma AT ernstdominikus casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma AT siepmanntimo casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma AT kaltofendorothea casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma AT hanelmathias casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma AT mirowlutz casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma |